Publications Search - Abstract View
||No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.
||Sabunciyan S, Mandelberg N, Rabkin CS, Yolken R, Viscidi R
||Mol Cell Probes
||New ELISA assays were developed to measure immunoreactivity for XMRV. Antibody titers were measured in a cohort of prostate cancer cases and cancer free controls from the central United States. No statistically significant differences were observed in immunoreactivity between cases and controls for either the XMRV-env or the XMRV-gag antigen.